Journey Medical (DERM) Total Current Liabilities (2020 - 2026)
Journey Medical's (DERM) quarterly Total Current Liabilities came in at $37.8 million in Q1 2026, down 5.95% YoY from $40.2 million in Q1 2025, and up 1.04% on a QoQ basis from $37.4 million in Q4 2025.
Journey Medical (DERM) Total Current Liabilities (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Total Current Liabilities data on file, last reported at $37.8 million in Q1 2026.
- Quarterly Total Current Liabilities fell 5.95% year-over-year to $37.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.8 million (down 5.95% YoY) and the FY2025 annual result came in at $37.4 million, up 6.44% from the prior year.
- Total Current Liabilities climbed to $37.8 million in Q1 2026, from $37.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $76.9 million in Q1 2023 to a low of $33.3 million in Q3 2024.
- A 5-year average of $48.3 million and a median of $40.5 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities gained 29.48% — and 2024, when it sank 49.93%.
- Tracing DERM's Total Current Liabilities over 5 years: stood at $66.8 million in 2022, then slumped by 37.35% to $41.9 million in 2023, then dropped by 15.99% to $35.2 million in 2024, then rose by 6.44% to $37.4 million in 2025, then advanced by 1.04% to $37.8 million in 2026.
- The last three Total Current Liabilities figures came in at $37.8 million (Q1 2026), $37.4 million (Q4 2025), and $39.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.79 Bn |
| 10 | Journey Medical | 205.38 Mn | 179.73 Mn | 12.37 Mn | 45.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.77 Mn |
| Mar 31, 2026 | 37.83 Mn |
| Dec 31, 2025 | 37.44 Mn |
| Sep 30, 2025 | 39.72 Mn |
| Jun 30, 2025 | 40.48 Mn |
| Mar 31, 2025 | 40.22 Mn |
| Dec 31, 2024 | 35.18 Mn |
| Sep 30, 2024 | 33.33 Mn |
| Jun 30, 2024 | 34.15 Mn |
| Mar 31, 2024 | 38.94 Mn |
| Dec 31, 2023 | 41.87 Mn |
| Sep 30, 2023 | 48.51 Mn |
| Jun 30, 2023 | 68.19 Mn |
| Mar 31, 2023 | 76.90 Mn |
| Dec 31, 2022 | 66.83 Mn |
| Sep 30, 2022 | 60.78 Mn |
| Jun 30, 2022 | 60.10 Mn |
| Mar 31, 2022 | 60.97 Mn |
| Dec 31, 2021 | 51.61 Mn |
| Sep 30, 2021 | 59.79 Mn |